Cardiff Transplant Unit, University Hospital of Wales, Cardiff, UK.
Welsh Renal Clinical Network, Cwm Taf Morgannwg University Health Board, Pontypridd, UK.
J Nephrol. 2021 Jun;34(3):829-838. doi: 10.1007/s40620-020-00869-z. Epub 2020 Dec 1.
Little is known regarding the impact of acute kidney injury (AKI) on renal transplant outcome. Our aim was to define the incidence and outcome of AKI in renal transplant patients using data collected from a national AKI electronic alert system METHODS: The study represents a prospective national cohort study collecting data on 1224 renal transplants recipients with a functioning renal transplant, between April 2015 and March 2019.
Four hundred forty patients experienced at least one episode of AKI giving an incidence rate of 35.4%. Sixty-four point seven% of episodes were AKI stage 1, 7.3% AKI stage 2 and 28% AKI stage 3. Only 6.2% of episodes occurred in the context of rejection. Forty-three point five% of AKI episodes were associated with sepsis. AKI was associated with pre-existing renal dysfunction, and a primary renal diagnosis of diabetic nephropathy. AKI was more prevalent in recipients from a donor after cardiac death (26.4% vs. 21.4%, p < 0.05) compared to the non-AKI cohort. Following AKI, 30-day mortality was 19.8% and overall mortality was 34.8%, compared to 8.4% in the non AKI cohort (RR 4.06, 95% CI 3.1-5.3, p < 0.001). Graft survival (GS), and death censored graft survival (DCGS) censored at 4 years, in the AKI cohort were significantly lower than in the non AKI group (p < 0.0001 for GS and DCGS).
The study provides a detailed characterisation of AKI in renal transplant recipients highlighting its significant negative impact on patient and graft survival.
急性肾损伤 (AKI) 对肾移植结局的影响知之甚少。我们的目的是使用从国家 AKI 电子警报系统收集的数据来定义肾移植患者 AKI 的发生率和结局。
该研究代表了一项前瞻性全国队列研究,共纳入了 1224 名肾功能正常的肾移植受者的数据,研究时间为 2015 年 4 月至 2019 年 3 月。
440 例患者至少发生了一次 AKI,发生率为 35.4%。64.7%的 AKI 为 1 期,7.3%为 2 期,28%为 3 期。只有 6.2%的 AKI 发生在排斥反应的背景下。43.5%的 AKI 与脓毒症有关。AKI 与术前肾功能不全和原发性肾脏诊断为糖尿病肾病有关。与非 AKI 队列相比,AKI 更常见于心源性死亡供者(26.4% vs. 21.4%,p<0.05)。AKI 后 30 天死亡率为 19.8%,总死亡率为 34.8%,而非 AKI 队列为 8.4%(RR 4.06,95%CI 3.1-5.3,p<0.001)。AKI 队列的移植物存活率(GS)和死亡截尾移植物存活率(DCGS)在 4 年时明显低于非 AKI 组(p<0.0001 用于 GS 和 DCGS)。
该研究详细描述了肾移植受者的 AKI,强调了其对患者和移植物存活率的显著负面影响。